Intera Atlas
Run match
Sites / Alliance Clinical Network
Is this you?

Request access for Alliance Clinical Network with your @allianceclinicalnetwork.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Alliance Clinical Network

Unclaimed profile

Site Network · Southlake, TX · ~4-6 sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 8Lift (cardio sample) 0.71Recruit soph 0.29
Quality Scorecard (1–100)
Overall85Recruit74Ops89Sponsor91Ther89

Performance (observed)

Historical trials
508
Completed
281
Terminated/Withdrawn
64
Completion rate
81%
Active now
157
Phase 2
148
Phase 3
327
Realized enrollment
1,084,357
First study year
1992
Years active
34
Match confidence
low (approx)
Enrollment velocity (inf)
31,893

Therapeutic

Areas
Metabolics & Obesity, Vaccines & Immunology, CNS, Dermatology, Cardiovascular, Gastroenterology, Women's Health, Infectious Disease, Pulmonology
Specialties
Metabolics/Obesity, Vaccines/Immunology, Women's Health, GI, Infectious Diseases, Internal Medicine, Pulmonology, Cardiovascular
Breadth (conditions)
771
Languages
English + Spanish (detected)
States
TX, CA, NV (wholly owned sites in Dallas, Lewisville, Las Vegas, Sacramento, Long Beach, San Diego area)

Recruitment (web observed)

Patient database
Y (500,000+ consented)
Advertises recruitment
Yes
SEO
Moderate (nimble sites content)
Capability notes
Very strong; 500K+ consented diverse database, 85%+ from underrepresented populations, 35-day site-to-screening

Relationships

Sponsors
Pfizer; Eli Lilly and Company; Gilead Sciences; Merck Sharp & Dohme LLC; National Cancer Institute (NCI); AbbVie
CROs
ICON Clinical Research; IQVIA Pty Ltd; PPD, Part of Thermo Fisher Scientific; Parexel; Premier Research; Syneos Health
Partnerships
Local hospital affiliations
Owner / parent
Privately held; founder Anthony Abey remains on Board
Expansion
N (established network, 3 states)

Capacity & people

Investigators
—
Coordinators
—
CEO
Anthony Milonas (appointed Nov 2025)
VP Clinical Ops
Jeanette Lee (VP Clinical Operations)
VP Site Ops
Unknown
VP Recruitment
Rebecca Lanier (VP Patient Recruitment)
Emails
Unknown (via allianceclinicalnetwork.com)

Tech & DCT

Uses AI
Yes
Builds tech
Builds internally
Home visits
Y
DCT / decentralized
Y (Texas, California, Nevada; 500K+ consented patients)
Tech stack
Proprietary enrollment strategies, participant identification/contact tech, centralized SOP platform, 100% overnight QC
Recruiting visible
Y

Notes

Wholly owned multistate site network (4-6 locations). Founded ~2010s, strategically positioned in high-enrollment areas (TX focus). 500K+ consented database, heavy diversity focus (85%+ underrep). Metabolics/obesity specialization (high-volume enrollment trend). Proprietary enrollment tech, 35-day startup. New leadership (Milonas, formerly Ascend Aesthetic CEO). Excellent Intera fit: multisite, recruitment-obsessed, diverse patient base, proprietary tech, fast startup, obesity focus. [Validated: 4 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 1.00Liftability 0.71Overall85

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.